A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.
NCT02021500
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
ABI-007
Sponsor
Celgene